Ranibizumab Intraocular and Sinemet CR 200/50
Determining the interaction of Ranibizumab Intraocular and Sinemet CR 200/50 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Sinequan
- Ranibizumab Intraocular-Sinequan (Doxepin Capsules)
- Ranibizumab Intraocular-Sinequan (Doxepin Oral Concentrate)
- Ranibizumab Intraocular-Sinex Long-Acting
- Ranibizumab Intraocular-Sinex Nasal Spray
- Ranibizumab Intraocular-Singulair
- Sinemet CR 200/50-Ranibizumab ophthalmic
- Sinemet CR 200/50-Ranitidine
- Sinemet CR 200/50-Ranitidine Capsule
- Sinemet CR 200/50-Ranitidine Hydrochloride
- Sinemet CR 200/50-Ranitidine Injection
- Sinemet CR 200/50-Ranitidine Suspension